Stem cell-reliant HIV vaccine launches animal studies in January

Posted by Leanne Kodsman on

Scientists at the Texas Biomedical Research Institute have big plans for a new treatment designed to help stop the transmission ofHIV.The San Antonio Express-News reports that in January they'll start testing a genetically engineeredvaccinein rhesus monkeys that interacts with epithelial stem cells to do its job.


Scientists at the Texas Biomedical Research Institute have big plans for a new treatment designed to help stop the transmission ofHIV.The San Antonio Express-News reports that in January they'll start testing a genetically engineeredvaccinein rhesus monkeys that interacts with epithelial stem cells to do its job.

Additionally, they've also applied for a patent for a single-dose HIV vaccine--one that would ideally last for a lifetime, by helping to stop the spread of HIV during sexual intercourse.

The team came up with a vaccine designed to hit stem cells in the mucosal layers of the epithelium with dead pieces of HIV, according to the story. The hope is that the stem cells would keep the HIV antigen as they morph into other skin cells and create an immune response that leaves a protective cell barrier.

Plans call for testing the vaccine with injections in the vagina, rectum, mouth or skin. After that, the scientific team will infect the monkeys with HIV to see how well the vaccine works. (It has already shown promise in the lab.) If all goes well, they will know if there is even greater promise here by 2015.

We'll wait to hear more, of course, but there are many years of animal testing ahead to know if there is enough promise to move into human trials. The Texas effort joins a number of research projects in both animal and human studies, and the race to have an approved HIV vaccine for people. Who will get there first It's still too early to tell.

Innovative Reserach has begun developing quality reagents and antibodies to conduct further research on HIV and HIV antibodies. You can view our latest and newest products by visiting www.innov-research.com.


    Innovative Research was established in 1998 after the realization that dependable, high-quality, and affordable research materials were hard to come by. Starting with core products like human plasma and serum, Innovative Research has grown to be a trusted supplier of all lab reagents, including human biologicals and ELISA kits. Today, we manufacture and supply thousands of high-quality human and animal biologicals including plasma, serum, tissues, and proteins.


Related Posts

PAI-1 Mutation in Amish Community Could Lead to New Treatments for Age-Related Disorders
In the early 1990s, a paper was published in the New England Journal of Medicine that d...
Read the Article
The case for PAI-1 as a biomarker for major depressive disorder and antidepressant resistance
If research dollars were allocated according to the extent of human distress, major dep...
Read the Article
Antigen, Abbreviated: Plasminogen Activator Inhibitor 1 (PAI-1)
What is PAI-1 and what does it do? Plasminogen Activator Inhibitor 1, commonly referred...
Read the Article

← Older Post Newer Post →